|
Hey Everyone: I was doing some research and came across this "good news":
"These data suggest that trastuzumab radically changes the natural history of HER2-positive metastatic breast cancer. While women with HER2-positive tumors have historically been thought to have a worse prognosis, the advent of trastuzumab means that they appear to do far better in response to chemotherapy than do patients with HER2-negative tumors, exhibiting higher rates of response, longer durations of treatment, and improved overall survival."
How about that!!!!
|